Farzan Nima
- SEC CIK
- 0001808296
Latest role at each company
- KROS Keros Therapeutics, Inc.Directoras of Jun 8, 2026
- CIK 0001797768CHIEF EXECUTIVE OFFICERas of Apr 5, 2024
Trades
Every Form 4 that lists Farzan Nima as a reporting owner, including filings made jointly with others. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Company | Filed (ET) | Trade date | Insider | Transaction | Shares | Avg price | Value | Shares after | Holding change | Filing |
|---|---|---|---|---|---|---|---|---|---|---|
| KROSKeros Therapeutics, Inc. | Jun 8, 2026 | Jun 4, 2026 | Farzan NimaDirector | SSaleCommon Stock | −2.63K | $10.73 | −$28.17K | 9.77K | −21.2% | SEC10b5-1 |